Roger Medel M.D., Chief Executive Officer at MEDNAX, INC. (MD), sold 61,592 shares at $62.52 ($3.9M) on 2014-10-31, disclosed to the SEC on 2014-10-31.
Scheduled sale ($3.9M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.63 | 36,509 | $2.3M | 59.3% |
| 2 | $62.52 | 25,083 | $1.6M | 40.7% |
| Total | $62.59 avg | 61,592 | $3.9M | 100% |
| Filing → |
| MD | SELL | 2022-01-04 | $5.1M | — | Filing → |
| MD | SELL | 2021-12-30 | $2.5M | — | Filing → |
| MD | SELL | 2021-12-29 | $6.7M | — | Filing → |